UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 224

Sortiert nach

Social phobia

Nervenarzt, 2014-05, Vol.85 (5), p.635-44; quiz 645-7

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy of anxiety disorders-Guideline-conform treatment and new developments

Nervenarzt, 2021-05, Vol.92 (5), p.433

2021

Link zum Volltext

Verfügbarkeit prüfen

S23-02 - Evidence-based treatment of anxiety disorders in Europe - an update

European psychiatry, 2011, Vol.26, p.2095-2095

Bandelow, B

2011

Link zum Volltext

Verfügbarkeit prüfen

Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety—an MRI study

European archives of psychiatry and clinical neuroscience, 2019-04, Vol.269 (3), p.285-294

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of venlafaxine extended-release compared with placebo in major depressive disorder patients by severity of anxiety symptoms

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, Vol.27, p.S807-S808

2017

Link zum Volltext

Verfügbarkeit prüfen

C.03.02 Comorbid depression and anxiety – understanding and treating complex patients

European neuropsychopharmacology, 2009, Vol.19, p.S706-S706

Bandelow, B

2009

Link zum Volltext

Verfügbarkeit prüfen

Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls

European archives of psychiatry and clinical neuroscience, 2016-09, Vol.266 (6), p.557-566

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

International clinical psychopharmacology, 1995-06, Vol.10 (2), p.73-82

Bandelow, B

1995

Link zum Volltext

Verfügbarkeit prüfen

Pharmakotherapie von Angsterkrankungen – leitliniengerechte Therapie und Neuentwicklungen

Nervenarzt, 2021-05, Vol.92 (5), p.433-440

2021

Link zum Volltext

Verfügbarkeit prüfen

Improvement of Borderline Personality Disorder with Naltrexone: Results of a Retrospective Evaluation

European psychiatry, 2015-03, Vol.30, p.668-668

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

International clinical psychopharmacology, 2009-03, Vol.24 (2), p.87

2009

Link zum Volltext

Verfügbarkeit prüfen

S.21.01 Treatment-resistant panic anxiety disorder

European neuropsychopharmacology, 2007, Vol.17, p.S207-S208

Bandelow, B

2007

Link zum Volltext

Verfügbarkeit prüfen

Long term treatment of anxiety disorders

European psychiatry, 2007-03, Vol.22, p.S73-S73

Bandelow, B

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological treatment of anxiety disorders - is there a state of the art?

European psychiatry, 2007-03, Vol.22, p.S90-S90

Bandelow, B

2007

Link zum Volltext

Verfügbarkeit prüfen

Soziale Phobie

Nervenarzt, 2014, Vol.85 (5), p.635-647

2014

Link zum Volltext

Verfügbarkeit prüfen

Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder

European archives of psychiatry and clinical neuroscience, 2004-12, Vol.254 (6), p.397-405

2004

Link zum Volltext

Verfügbarkeit prüfen

Network analyses to rank pharmacological treatments for generalised anxiety disorder

The Lancet (British edition), 2019-02, Vol.393 (10173), p.721-722

2019

Link zum Volltext

Verfügbarkeit prüfen

Rgs 2 gene polymorphisms as modulators of anxiety in humans?

Journal of Neural Transmission, 2006-12, Vol.113 (12), p.1921-1925

2006

Link zum Volltext

Verfügbarkeit prüfen

Guideline-oriented inpatient psychiatric psychotherapeutic/psychosomatic treatment of anxiety disorders : How many personnel are need?

Nervenarzt, 2016-03, Vol.87 (3), p.302-310

2016

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Journal of psychopharmacology (Oxford), 2014-05, Vol.28 (5), p.403-439

2014

Link zum Volltext

Verfügbarkeit prüfen

P.4.c.002 Clinical suitability of GAD-7 scale compared to hospital anxiety and depression scale-A for monitoring treatment effects in generalized anxiety disorder

European neuropsychopharmacology, 2009, Vol.19, p.S604-S605

2009

Link zum Volltext

Verfügbarkeit prüfen

Social anxiety disorder--diagnostics and treatment options

Fortschritte der Neurologie, Psychiatrie, 2008-10, Vol.76 (10), p.616

2008

Link zum Volltext

Verfügbarkeit prüfen

P02-412 - Borderline personality disorder - a dysregulation of the endogenous opioid system?

European psychiatry, 2011, Vol.26, p.1008-1008

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia

Acta psychiatrica Scandinavica, 2005-02, Vol.111 (2), p.106-115

2005

Link zum Volltext

Verfügbarkeit prüfen

Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder

Current pharmaceutical design, 2008-11, Vol.14 (33), p.3518

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 224

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Englisch
(164)
Deutsch
(59)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(106)
Science & Technology
(96)
Psychiatry
(95)
Life Sciences & Biomedicine
(90)
Male
(61)
Adult
(58)
Female
(57)
Neurosciences & Neurology
(43)
Biological And Medical Sciences
(41)
Medical Sciences
(36)
Middle Aged
(34)
Psychology. Psychoanalysis. Psychiatry
(34)
Clinical Neurology
(33)
Panic Disorder
(28)
Psychopathology. Psychiatry
(26)
Neurosciences
(22)
Pharmacology & Pharmacy
(22)
Adolescent
(20)
Panic Disorder - Psychology
(20)
Treatment Outcome
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Social phobia

Pharmacotherapy of anxiety disorders-Guideline-conform treatment and new developments

S23-02 - Evidence-based treatment of anxiety disorders in Europe - an update

Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety—an MRI study

Efficacy of venlafaxine extended-release compared with placebo in major depressive disorder patients by severity of anxiety symptoms

C.03.02 Comorbid depression and anxiety – understanding and treating complex patients

Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls

Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

Pharmakotherapie von Angsterkrankungen – leitliniengerechte Therapie und Neuentwicklungen

Improvement of Borderline Personality Disorder with Naltrexone: Results of a Retrospective Evaluation

Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

S.21.01 Treatment-resistant panic anxiety disorder

Long term treatment of anxiety disorders

Pharmacological treatment of anxiety disorders - is there a state of the art?

Soziale Phobie

Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder

Network analyses to rank pharmacological treatments for generalised anxiety disorder

Rgs 2 gene polymorphisms as modulators of anxiety in humans?

Guideline-oriented inpatient psychiatric psychotherapeutic/psychosomatic treatment of anxiety disorders : How many personnel are need?

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

P.4.c.002 Clinical suitability of GAD-7 scale compared to hospital anxiety and depression scale-A for monitoring treatment effects in generalized anxiety disorder

Social anxiety disorder--diagnostics and treatment options

P02-412 - Borderline personality disorder - a dysregulation of the endogenous opioid system?

Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia

Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder

Suchergebnisse filtern